Phase 3 Prematurity Clinical Trials
7 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–7 of 7 trials
Recruiting
Phase 2Phase 3
Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress
Respiratory DiseaseVentilator Lung; NewbornPrematurity
Ministry of Health, Saudi Arabia134 enrolled2 locationsNCT06026163
Recruiting
Phase 3
Intranasal Dexmedetomidine for Pain Management During Screening for Retinopathy of Prematurity
Retinopathy of PrematurityDexmedetomidine
Assaf-Harofeh Medical Center30 enrolled1 locationNCT06067958
Recruiting
Phase 2Phase 3
Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome
Retinopathy of Prematurity
Asociación para Evitar la Ceguera en México1 locationNCT00346814
Recruiting
Phase 3
Doxapram Therapy in Preterm Infants (DOXA Trial)
Apnea of PrematurityRespiratory Insufficiency
Erasmus Medical Center396 enrolled24 locationsNCT04430790
Active
Phase 3
Efficacy and Demonstration of IntraVenous Iron for Anaemia in pregnancy (EDIVA)
Low birthweightAnaemiaPrematurity
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)900 enrolled1 locationACTRN12621000968875
Completed
Phase 3
Randomized controlled trial of the Effect of intraVenous iron on Anaemia in Malawian Pregnant women
Infant anaemiaMaternal mortalityFatigue+5 more
University of Malawi, College of Medicine862 enrolled1 locationACTRN12618001268235
Withdrawn
Phase 3Phase 4
Oral paracetamol versus intravenous Ibuprofen for the treatment of patent Ductus arteriosus in premature infants: A Pilot Randomised Trial (The OVID Trial)
Prematurity
Monash Newborn60 enrolled1 locationACTRN12614000754640